I'm not sure that's entirely correct. The first timeline we saw for azer-cel (at the time of purchase) targeted Q3 2024 for a Phase 1b readout, so 2H 2024 is still accurate.
The more recent JPM slides show 2 updates for azer-cel across 2024 one in Q2 (enrolment) and one in Q3 (readout). So I don't think the timeline there has slipped at all?
And as far as no immediate updates, I would think, given Vaxinia's preliminary enrolment update of April 24 '24, that the next data cut would not be too far off. To speculate, I *think* they would want to see all Cohort 5 patients cross the 42 day mark first. So as of April 24, there are still 7 Cohort 5 patients that have not yet had their 42 day scan.
Perhaps June for the next cut? Or maybe we're lucky and will see something mid May.
GLTAH.
- Forums
- ASX - By Stock
- IMU
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-39
-
- There are more pages in this discussion • 81 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.9¢ |
Change
0.001(2.08%) |
Mkt cap ! $364.4M |
Open | High | Low | Value | Volume |
4.8¢ | 4.9¢ | 4.8¢ | $179.8K | 3.692M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
62 | 8124186 | 4.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.9¢ | 3070575 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
56 | 7804777 | 0.048 |
47 | 5437350 | 0.047 |
38 | 3197542 | 0.046 |
58 | 3766545 | 0.045 |
11 | 1019564 | 0.044 |
Price($) | Vol. | No. |
---|---|---|
0.049 | 2050167 | 7 |
0.050 | 5223480 | 23 |
0.051 | 4434080 | 10 |
0.052 | 2536519 | 9 |
0.053 | 1966973 | 9 |
Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |